Safety and efficacy with alemtuzumab over 13 years in relapsing-remitting multiple sclerosis: final results from the open-label TOPAZ study

MS Treatments

Jahr

Publikationsjahr
2023

Autoren

Autorenliste der Publikation
Coles AJ, Achiron A, Traboulsee A, Singer BA, Pozzilli C, Oreja-Guevara C, Giovannoni G, Comi G, Freedman MS, Ziemssen T, Shiota D, Rawlings AM, Wong AT, Chirieac M, Montalban X.

Verlag

Publisher-Information
Ther Adv Neurol Disord. 2023 Sep 21;16:17562864231194823.

Link

Zur Publikation (externer Server)
https://doi.org/10.1177/17562864231194823

Tags

Forschungsthemen
Multiple SkleroseMS Behandlung
TreatmentsMSZ2023